Results 1 to 10 of about 10,740,045 (356)

Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study

Annals of the Rheumatic Diseases, 2021
Introduction Vaccination represents a cornerstone in mastering the COVID-19 pandemic. Data on immunogenicity and safety of messenger RNA (mRNA) vaccines in patients with autoimmune inflammatory rheumatic diseases (AIIRD) are limited.
V. Furer, T. Eviatar, D. Zisman, H. Peleg, D. Paran, D. Levartovsky, M. Zisapel, O. Elalouf, I. Kaufman, R. Meidan, A. Broyde, A. Polachek, J. Wollman, I. Litinsky, K. Meridor, H. Nochomovitz, Adi Silberman, D. Rosenberg, J. Feld, A. Haddad, Tal Gazzit, M. Elias, N. Higazi, F. Kharouf, G. Shefer, O. Sharon, S. Pel, S. Nevo, O. Elkayam   +28 more
semanticscholar   +1 more source

Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry

Annals of the Rheumatic Diseases, 2021
Objectives To determine factors associated with COVID-19-related death in people with rheumatic diseases. Methods Physician-reported registry of adults with rheumatic disease and confirmed or presumptive COVID-19 (from 24 March to 1 July 2020).
Anja Strangfeld, M. Schäfer, M. Gianfrancesco, S. Lawson-Tovey, J. Liew, L. Ljung, E. Mateus, C. Richez, M. Santos, G. Schmajuk, C. Scirè, E. Sirotich, J. Sparks, P. Sufka, T. Thomas, L. Trupin, Z. Wallace, Sarah Al-Adely, J. Bachiller-Corral, S. Bhana, P. Cacoub, L. Carmona, R. Costello, W. Costello, L. Gossec, R. Grainger, E. Hachulla, R. Hasseli, J. Hausmann, K. Hyrich, Z. Izadi, L. Jacobsohn, P. Katz, L. Kearsley‐Fleet, P. Robinson, J. Yazdany, P. Machado   +36 more
semanticscholar   +1 more source

Vitamin D and Autoimmune Rheumatic Diseases

Biomolecules, 2023
Vitamin D is a steroid hormone with potent immune-modulating properties. It has been shown to stimulate innate immunity and induce immune tolerance. Extensive research efforts have shown that vitamin D deficiency may be related to the development of ...
L. Athanassiou, I. Kostoglou-Athanassiou, M. Koutsilieris, Y. Shoenfeld   +3 more
semanticscholar   +1 more source

Gut dysbiosis in rheumatic diseases: A systematic review and meta-analysis of 92 observational studies

EBioMedicine, 2022
Summary Background Emerging evidence suggests that dysbiosis in gut microbiota may contribute to the occurrence or development of several rheumatic diseases.
Yilun Wang, Jie Wei, Weiya Zhang, Michael Doherty, Yuqing Zhang, Haibin Xie, Wei Li, Ning-Rong Wang, G. Lei, C. Zeng   +9 more
semanticscholar   +1 more source

Safety and immunogenicity of inactivated COVID-19 vaccination in adult rheumatic patients in South China: a prospective study

Human Vaccines & Immunotherapeutics, 2022
Patients with rheumatic diseases (RD) are considered to be a high-risk population for infection with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
Huiqiong Zeng, Hanjiang Liu, Zhi Liu, Xiakai Zhou, Xiaoping Lu, Zhenbo Yan, Yan Zhou, Liping Dai, Yashuo Chen, Tingting Yang, Zhihua Yin, Zhizhong Ye   +11 more
doaj   +1 more source

Autoimmune Rheumatic Diseases [PDF]

BioMed Research International, 2014
The term autoimmune rheumatic diseases (ARDs) encompasses a heterogeneous group of conditions characterized by joint involvement along with a wide spectrum of systemic manifestations. The most common ARDs are rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). Nevertheless, all these conditions share similar pathophysiological mechanisms [
Anaya, Juan Manuel, Shoenfeld, Yehuda, Buttgereit, Frank, González-Gay Mantecón, Miguel Ángel   +3 more
openaire   +5 more sources

2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases

Arthritis care & research, 2023
To provide evidence‐based recommendations on the use of vaccinations in children and adults with rheumatic and musculoskeletal diseases (RMDs).
A. Bass, E. Chakravarty, E. Akl, Clifton O. Bingham, L. Calabrese, L. Cappelli, S. Johnson, L. Imundo, K. Winthrop, R. Arasaratnam, Lindsey R. Baden, R. Berard, S. Bridges, Jonathan T. L. Cheah, J. R. Curtis, Polly J. Ferguson, I. Hakkarinen, K. Onel, Grayson Schultz, V. Sivaraman, Benjamin J. Smith, J. Sparks, Tiphanie P Vogel, E. Williams, C. Calabrese, Joanne S. Cunha, J. Fontanarosa, M. Gillispie-Taylor, E. Gkrouzman, Priyanka Iyer, K. Lakin, A. Legge, Mindy S. Lo, M. M. Lockwood, R. Sadun, Namrata Singh, Nancy M. Sullivan, H. Tam, Marat Turgunbaev, Amy S. Turner, J. Reston   +40 more
semanticscholar   +1 more source

COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations

Nature Reviews Rheumatology, 2022
The COVID-19 pandemic has brought challenges for people with rheumatic disease in addition to those faced by the general population, including concerns about higher risks of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and ...
R. Grainger, A. Kim, R. Conway, J. Yazdany, P. Robinson   +4 more
semanticscholar   +1 more source

LncRNA H19 induces immune dysregulation of BMMSCs, at least partly, by inhibiting IL-2 production

Molecular Medicine, 2021
Background Systemic lupus erythematosus (SLE) is a representative systemic autoimmune disease. LncRNA H19 has been identified to participate in various biological processes in human diseases. However, the role of H19 in SLE remains unclear.
Xinpeng Chen, Xiuxia Luo, Yazhi Wei, Hualin Sun, Liping Dai, Yidou Tangzhou, Huijie Jin, Zhihua Yin   +7 more
doaj   +1 more source

Role of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview

Frontiers in Immunology, 2021
Interleukin-23 (IL-23) is a pro-inflammatory cytokine composed of two subunits, IL-23A (p19) and IL-12/23B (p40), the latter shared with Interleukin-12 (IL-12).
C. Schinocca, C. Rizzo, S. Fasano, G. Grasso, L. La Barbera, F. Ciccia, G. Guggino   +6 more
semanticscholar   +1 more source